| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2134628 | Experimental Hematology | 2011 | 13 Pages |
Abstract
These results suggest that the success of strategies aimed at telomerase inhibition in CML is highly dependent on the presence of functional p53 and should be explored preferentially in chronic phase CML.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ute Brassat, Stefan Balabanov, Daniel Bali, Judith Dierlamm, Melanie Braig, Ulrike Hartmann, Hüseyin Sirma, Cagatay Günes, Henning Wege, Boris Fehse, Artur Gontarewicz, Ekkehard Dikomey, Kerstin Borgmann, Tim H. Brümmendorf,